Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4869984 | 0.81 | LMNA (0.44) | ALDH1A1 | |
| SCHEMBL5793825 | 0.78 | ALDH1A1 (0.41) | ALDH1A1 | |
| SCHEMBL19225697 | 0.74 | ALDH1A1 (0.41) | ALDH1A1 | |
| SCHEMBL20585106 | 0.72 | ALDH1A1 (0.40) | ALDH1A1 | |
| SCHEMBL17529259 | 0.71 | ACHE (0.39) | ALDH1A1 | |
| SCHEMBL16309640 | 0.71 | ALDH1A1 (0.40) | ALDH1A1 | |
| SCHEMBL22368948 | 0.69 | ALDH1A1 (0.34) | ALDH1A1 | |
| SCHEMBL21637950 | 0.67 | MAPT (0.38) | ALDH1A1 | |
| Ethane SCHEMBL29266735 | 0.66 | ALDH1A1 (0.57) | ALDH1A1 | |
| SCHEMBL2064114 | 0.65 | ALDH1A1 (0.41) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8183382-B2 | ruthenium transition metal complexes used as cyclization catalyst | EVONIK DEGUSSA GMBH (DE) | 2012-05-22 | — | — | US | disclosed |
| US-8183382-B2 | ruthenium transition metal complexes used as cyclization catalyst | EVONIK DEGUSSA GMBH (DE) | 2012-05-22 | — | — | US | disclosed |
| EP-1990348-A2 | Metathesis catalysts containing sulphur | Evonik Degussa GmbH (DE) | 2008-11-12 | — | — | EP | disclosed |
| US-20080275247-A1 | SULPHUR-CONTAINING METATHESIS CATALYSTS | EVONIK DEGUSSA GMBH (DE) | 2008-11-06 | — | — | US | disclosed |
| US-20080275247-A1 | SULPHUR-CONTAINING METATHESIS CATALYSTS | EVONIK DEGUSSA GMBH (DE) | 2008-11-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080275247-A1 | SULPHUR-CONTAINING METATHESIS CATALYSTS | TST, MPST, CBS | ALDH1A1 293/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.